event,time
male ,0.0
premature birth ,0.0
emergency cesarean delivery ,0.0
abruptio placenta ,0.0
birth weight 1090g ,0.0
Apgar 4 and 8 ,0.0
respiratory distress ,0.0
respiration rate 65 breaths per min ,0.0
chest retraction ,0.0
CPAP machine ,0.0
positive end expiratory pressures 6 ,0.0
inspired oxygen 30% ,0.0
cloudy eyes ,0.0
ectropion ,0.0
dry ichthyotic skin ,0.0
typical male genitalia ,0.0
bilateral undescended testicles ,0.0
height 75th percentile ,0.0
weight 25th percentile ,0.0
head circumference 25th percentile ,0.0
temperature 36.2Â°C ,0.0
heart rate 167 beats per min ,0.0
normal neurological examination ,0.0
normal breath sounds ,0.0
no organomegaly ,0.0
normal blood count ,0.0
normal electrolytes ,0.0
normal liver function ,0.0
respiratory distress syndrome ,0.0
ground-glass opacity on X-ray ,0.0
minor respiratory acidosis ,0.0
surfactant dosage ,0.0
continued CPAP assistance ,12.0
bowel movement ,12.0
trophic feeding ,72.0
breast milk ,72.0
abdominal distension ,144.0
tachycardia ,144.0
tachypnea ,144.0
thrombocytopenia ,144.0
neutropenia ,144.0
raised C-reactive protein ,144.0
meropenem ,144.0
vancomycin ,144.0
stopped tropic feeding ,216.0
antibiotics discontinued ,216.0
feeding restarted ,216.0
high-flow oxygen treatment ,336.0
relapses of unexplained apnea ,504.0
septic examination negative ,504.0
brain MRI normal ,504.0
nasogastric tube ,504.0
conjugated hyperbilirubinemia ,504.0
neonatal cholestasis workup ,504.0
persistent conjugated hyperbilirubinemia ,504.0
total bilirubin 69.8 umol/L ,504.0
total parenteral nutrition ,504.0
genetic studies ,504.0
X-ray of spine normal ,504.0
echocardiogram normal ,504.0
eye test normal ,504.0
skull X-ray showed craniosynostosis ,504.0
hepatosplenomegaly not seen ,504.0
normal-appearing gallbladder ,504.0
no signs of biliary atresia ,504.0
albumin level decline ,504.0
bilirubin rise ,504.0
AST rise ,504.0
ALT rise ,504.0
multiple albumin infusions ,504.0
infectious etiology investigation ,504.0
TSH normal ,504.0
T3 normal ,504.0
T4 normal ,504.0
cortisol normal ,504.0
metabolic disorders negative ,504.0
galactosemia negative ,504.0
tyrosinemia type 1 negative ,504.0
whole-exome sequencing ,672.0
NOTCH2 gene mutation ,672.0
heterozygous variant c.1076c>T ,672.0
p. (Ser359Phe) ,672.0
chr1: 120512166 ,672.0
severe cyanosis ,936.0
apnea ,936.0
bradycardia ,936.0
cardio-respiratory resuscitation ,936.0
intubation ,936.0
mechanical breathing ,936.0
epinephrine ,936.0
septic shock ,936.0
multiorgan failure ,936.0
disseminated intravascular coagulation ,936.0
acute renal damage ,936.0
capillary leak syndrome ,936.0
death ,2400.0
NOTCH2 gene ,-2400.0
ALGS2 ,-2400.0
pathogenic variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
heterozygous ,-2400.0
autosomal dominant ,-2400.0
neonatal cholestasis ,-2400.0
cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS ,-2400.0
JAG1 ,-2400.0
NOTCH2 ,-2400.0
craniosynostosis ,-2400.0
ichthyosis ,-2400.0
respiratory distress syndrome ,-2400.0
sepsis ,-2400.0
biliary atresia ,-2400.0
TPN-associated cholestasis ,-2400.0
Hajdu-Cheney syndrome ,-2400.0
Serpentine fibula polycystic renal syndrome ,-2400.0
cancer ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
neonatal intensive care unit ,-2400.0
pediatric gastroenterology ,-2400.0
clinical nutrition ,-2400.0
liver transplantation ,-2400.0
whole-exome sequencing ,-2400.0
next-generation sequencing ,-2400.0
NOTCH2 gene sequencing ,-2400.0
 Twist Family BHLH Transcription Factor 1 ,-2400.0
TWIST1 ,-2400.0
JAG1/NOTCH ,-2400.0
NOTCH2 signaling ,-2400.0
NOTCH2 mutation ,-2400.0
ALGS2 diagnosis ,-2400.0
cholestasis gene panel ,-2400.0
neonatal cholestasis ,-2400.0
genetic testing ,-2400.0
molecular diagnosis ,-2400.0
genetic counseling ,-2400.0
familial screening ,-2400.0
NOTCH2 gene mutation ,-2400.0
heterozygous variant ,-2400.0
c.1076c>T ,-2400.0
p. (Ser359Phe) ,-2400.0
chr1: 120512166 ,-2400.0
autosomal dominant ,-2400.0
ALGS2 ,-2400.0
neonatal cholestasis ,-2400.0
liver disease ,-2400.0
genetic disorder ,-2400.0
NOTCH2 mutation ,
